Clinical trial
Ginkgo Biloba Extract and the Insulin Resistance Syndrome
NCT00032474 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00032474 |
|---|---|
| Title | Ginkgo Biloba Extract and the Insulin Resistance Syndrome |
| Official title | Ginkgo Biloba Extract and the Insulin Resistance Syndrome |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Ginkgo biloba extract |
| Enrollment | 150 |
| Start date | Dec 1, 2001 |
| Completion | May 1, 2005 |
| First posted | Mar 22, 2002 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: